|
REDCap / R Best Practices
|
|
1
|
4278
|
April 25, 2023
|
|
Not randomized and no intervention assigned/delivered - what next?
|
|
3
|
1590
|
April 20, 2023
|
|
FDA response to Citizen Petition to include Quality of Life comparisons in RCTs
|
|
2
|
1219
|
April 5, 2023
|
|
Minimal Detectable Change (MDC) vs Minimal Clinically Important Difference (MCID)
|
|
6
|
7028
|
March 22, 2023
|
|
Choice of study design
|
|
0
|
743
|
March 20, 2023
|
|
Randomization in a diagnostic study - necessary?
|
|
3
|
1560
|
March 16, 2023
|
|
Sample size estimation for observational studies using Bayesian methods
|
|
2
|
1348
|
March 15, 2023
|
|
Spectrum bias in multi-center case-control design
|
|
0
|
1028
|
February 23, 2023
|
|
Predictor measurement reliability
|
|
2
|
906
|
February 4, 2023
|
|
What is the type of my study, case control or retrospective cohort?
|
|
6
|
1703
|
January 27, 2023
|
|
Forest Plot reading-confusion
|
|
4
|
8385
|
December 22, 2022
|
|
Multiple linear regression for comparison of diagnostic tests
|
|
1
|
777
|
December 21, 2022
|
|
The Clinical and Statistical Saga of Thrombolysis in Acute Ischemic Stroke
|
|
11
|
3095
|
December 21, 2022
|
|
Article: JAMA meta-analysis of Placebo response and cannabis based therapies for pain
|
|
2
|
1422
|
December 3, 2022
|
|
Test-retest reliability and responsiveness of health status questionnaires
|
|
3
|
1328
|
November 19, 2022
|
|
Bayesian sample size calculation
|
|
1
|
4602
|
January 18, 2021
|
|
Guidelines for Covariate Adjustment in RCTs
|
|
62
|
34748
|
October 9, 2022
|
|
Language regarding confidence in "negative" results
|
|
0
|
951
|
October 5, 2022
|
|
Sample size linear regression
|
|
3
|
3353
|
September 18, 2022
|
|
Can I conduct an exploratory cross-over study on data originally collected in a clinical trial?
|
|
0
|
860
|
September 7, 2022
|
|
Cdisc in academia
|
|
1
|
1376
|
September 7, 2022
|
|
From observed event rates to event rate per anno and 5-year risk
|
|
1
|
1319
|
August 31, 2022
|
|
How can the change in exposure be taken into account in the survival analysis?
|
|
1
|
1040
|
August 12, 2022
|
|
Inventory/Cost of Goods
|
|
1
|
2106
|
July 9, 2022
|
|
Predicting rare outcomes
|
|
8
|
4993
|
June 26, 2022
|
|
Discussion on reconstructing data
|
|
4
|
4610
|
June 22, 2022
|
|
Article(s): Coffee Benefits and Continuous vs. Categorical Variable Analysis
|
|
3
|
2627
|
June 19, 2022
|
|
Study Design for Subjective Multinomial Outcome
|
|
7
|
3698
|
June 6, 2022
|
|
What type of study design can best describe this Study?
|
|
0
|
1703
|
June 2, 2022
|
|
Should adverse effects be adjusted for multiple comparisons?
|
|
4
|
3704
|
May 24, 2022
|